
COO at @reaganudall Foundation for the FDA.
Washington, DC
Joined August 2011
- Tweets2.3K
- Following0
- Followers370
- Likes95
Amar Bhat retweeted
Read about @reaganudall learnings from our #COVID19 vaccine confidence project with @US_FDA
#COVID19 #TwitteRx #pharmacists
japha.org/article/S1544-3191…
Amar Bhat retweeted
Register today! reaganudall.org/news-and-eve…
Amar Bhat retweeted
April is National Minority Health Month! FDA’s Office of Minority Health and Health Equity has a ton of great resources about COVID-19 and vaccines. Take a look! fda.gov/consumers/minority-h…
Amar Bhat retweeted
What a wonderful program! Thanks to the current and former @FDA Commissioners and to the great @reaganudall staff and Board for an inspiring program. Most of all, thanks to all @FDA staff for the great work you do on behalf of people everywhere!
Cheers to a great evening celebrating with our friends and colleagues! A big thank you to everyone who joined us to celebrate this year’s honorees at our 2020 Innovations in Regulatory Science Awards celebration. #InnovationsAwards20
Amar Bhat retweeted
Something I think we have to be really careful to communicate: these vaccines are not side-effect-free. Lots of injection site reactions. Lots of headaches. Lots of chills. And a few other things to watch.
statnews.com/2020/12/08/fda-…
Amar Bhat retweeted
At today’s #COVID19 Diagnostics #EvidenceAccelerator lab meeting, we’ll examine what’s working and what’s not in COVID testing in schools. @ColbyCollege and @RockefellerFdn will be presenting their strategies and learnings.
Amar Bhat retweeted
Congratulations to @US_FDA's @DrAbernethyFDA, the 2020 Innovations in Regulatory Science Awards Leadership honoree. Proud to recognize Dr. Abernethy’s unwavering leadership throughout her career in public service and her commitment to America’s public health. #InnovationsAwards20
Amar Bhat retweeted
Last week the #COVID19 #EvidenceAccelerator took a break from its typical data-focused discussions to look to prior pandemics for lessons on how we should approach COVID-19 response and treatment. https://teapawt.net/t.co/wa72jDm0D4
Amar Bhat retweeted
Excited to announce our new #COVID19 Diagnostics #EvidenceAccelerator that applies real-world data to answer urgent questions on SARS-CoV-2 testing. https://teapawt.net/t.co/JCBlS6zsak @CancerResrch
Amar Bhat retweeted
Have you checked our #COVID19 Hub lately? We update it daily as new companies, trials, and resources become available. https://teapawt.net/t.co/eb1dYJ8nWi
Amar Bhat retweeted
Read @BioCentury's article, “The pivotal role of real-world data in a pandemic,” which highlights our #COVID19 #EvidenceAccelerator, in collaboration with @CancerResrch. biocentury.com/article/30532…
Amar Bhat retweeted
"Scalable Approaches to Define and Document Natural History" was the theme for last week’s #EvidenceAccelerator lab meeting. Read how a solid understanding of natural history of #COVID19 provides insights into critical priorities: https://teapawt.net/t.co/R13cqk3jH4 @CancerResrch
Amar Bhat retweeted
Read @TriageCancer’s article which mentions the our Expanded Access Navigator and how it helps “healthcare providers, patients, and caregivers quickly identify investigational drugs, and streamline the physician/drug company communication process.” https://teapawt.net/t.co/QZ2GRV4bRH
Amar Bhat retweeted
Only FIVE days left to submit your nomination for an Innovations in Regulatory Science Award. Help us recognize an extraordinary leader, innovator, or advocate: https://teapawt.net/t.co/5gV6irrcuy
Amar Bhat retweeted
Amid #COVID19, it’s important to allow data to flow on “data elements we agree on.” Our COVID-19 Evidence Accelerator, in collaboration with @CancerResrch, championed by regulators like @DrAbernethyFDA, is in @NRO: A New, Better Normal in Health Care? https://teapawt.net/t.co/tB1PbmJ4N8
Amar Bhat retweeted
You can still nominate a person, team, or organization for an Innovations in Regulatory Science Award. Nomination deadline is May 31. More: https://teapawt.net/t.co/5gV6irrcuy
Amar Bhat retweeted
Don Kennedy had so many accomplishments. In addition to @US_FDA Commissioner, he was Editor-in-Chief of @ScienceMagazine, and President of @Stanford University. Extraordinary life of service and leadership.
This Post is from an account that no longer exists. Learn more






















